News And Announcements
Apple to expand iPhone satellite capability with £1.5bn commitment
Apple strengthened its partnership with satellite communications firm Globalstar, it was reported on Friday, by committing around $1. 5bn to expand iPhone satellite services, according to a recent securities filing.
Ryanair could cut UK flights by up to 10% after APD increase
Ryanair said on Friday that it could cut up to 10% of its scheduled flights to and from UK airports next year, as it criticised the government’s decision to increase the tax on airline tickets in the Budget.
Global Petroleum full-year losses narrow
Global Petroleum reported a loss after tax of $1. 04m in its final results on Friday, narrowing from $1. 28m year-on-year.
Kodal agrees transfer of Bougouni licence with Mali government
Kodal Minerals announced on Friday that it has reached an agreement with the government of Mali for the transfer of the Bougouni Lithium Project’s mining licence to its Malian subsidiary, Les Mines de Lithium de Bougouni (LMLB).
Boohoo appoints Dan Finley as CEO
Boohoo said on Friday that it has appointed the current boss of Debenhams, Dan Finley, as its new chief executive, just days after shareholder Frasers Group urged the online fashion retailer to replace its CEO with Mike Ashley.
Hummingbird reports progress with financial restructuring
Hummingbird Resources updated the market on its financial restructuring efforts with primary lenders Coris and CIG on Friday, along with its largest shareholder Nioko Resources Corporation.
Challenger Energy finance chief steps down
Challenger Energy Group announced the resignation of chief financial officer Gagan Khurana on Friday, effective immediately, due to personal reasons.
Emmerson launches formal dispute with Moroccan government
Potash development company Emmerson announced on Friday that it has formally notified the Moroccan government of an investment dispute, citing breaches of the 1990 Bilateral Investment Treaty (BIT) between the UK and Morocco.
Ondine raising £8.5m to fund US clinical trial
Ondine Biomedical announced a proposed minimum £8. 5m fundraising through a placing and subscription of new shares on Friday, priced at 8. 5p each, to support the US phase three clinical trial of its nasal photodisinfection system, ‘Steriwave’.
CAP-XX raises £2.75m in oversubscribed placing
CAP-XX announced on Friday that it has successfully raised £2. 75m in an oversubscribed placing and subscription, ahead of expenses.
ECR Minerals enters exclusivity deal for potential sale of MGA
ECR Minerals announced on Friday that it has entered into an exclusivity agreement for the potential sale of its subsidiary Mercator Gold Australia (MGA), including around AUD 75m (£38. 14m) in tax losses.
Solid State acquires Q-Par Antennas USA
Value-added components supplier Solid State has acquired Q-Par Antennas USA for a maximum consideration of up to $2. 0m.
Residential Secure Income changes asset management arrangements
Residential Secure Income announced changes to its asset management arrangements on Friday, following the launch of a new partnership between Gresham House and Thriving Investments.
Secure Trust Bank warns on profits amid vehicle finance difficulties
Secure Trust Bank reported continued growth in new business volumes and net lending in an update on Friday, although challenges in its vehicle finance segment led to a downgrade in its underlying profit expectations.
Minoan announces measures to reduce liabilities
Minoan Group announced further measures to reduce its liabilities and update its financing strategy on Friday.
Helical sells share in JJ Mack Building for £71.4m
Helical announced on Friday that it has completed the sale of its 50% interest in the JJ Mack Building, London EC1, to joint venture partner AshbyCapital for £71. 4m.
CMC Markets enters partnership with New Zealand's ASB
CMC Markets announced a strategic partnership with New Zealand bank ASB on Friday, marking a significant expansion into the Australia-New Zealand region.
Reckitt, Abbott cleared of liability in latest baby formula trial
Consumer health products group Abbott and Reckitt have been cleared of liability in a trial investigating whether they hid bowel disease risks associated with premature-baby formula.